Search for: "Johnson v. Case" Results 2321 - 2340 of 7,874
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2014, 9:24 am by Howard Friedman
LEXIS 23038 (D MD, Feb. 24, 2014), a Maryland federal district court dismissed a complaint by a Wiccan inmate that his celebration of the Samhain Feast was impaired when authorities refused to allow Wiccans to prepare and serve pork products through the prison kitchen facilities.In Johnson v. [read post]
15 Mar 2022, 9:20 am by Andrea Gass
Examples of rewritten cases include the law school staple Johnson v. [read post]
1 Oct 2019, 6:14 am by Carolina Attorneys
When the proceedings resumed later that afternoon, the State’s attorney stated that he had found case law that he believed allowed the trial to proceed in Defendant’s absence, directing the trial court’s attention to State v. [read post]
14 Dec 2009, 12:46 pm by Jenny Rempel
The Supreme Court adopted this standard from the ALI’s Model Penal Code §210.6 during the 1976 case Gregg v. [read post]
3 Oct 2018, 11:26 am by John Elwood
§ 2255 motion filed within one year of Johnson v. [read post]
18 Jul 2019, 1:10 pm by Lundgren & Johnson, PSC
The first published case to determine the admissibility of expert testimony regarding retrograde extrapolation was State v. [read post]
18 Jul 2019, 1:10 pm by Lundgren & Johnson, PSC
The first published case to determine the admissibility of expert testimony regarding retrograde extrapolation was State v. [read post]
22 Jun 2023, 9:05 am by Second Circuit Civil Rights Blog
Every now and then, the Court of Appeals offers guidance on this process.The case is A.C. v. [read post]
14 Oct 2015, 3:12 am by Amy Howe
Yesterday’s oral argument in Montgomery v. [read post]
18 Nov 2014, 2:42 am by Amy Howe
At the Civil Procedure & Federal Courts Blog, Adam Steinman analyzes last week’s per curiam decision in Johnson v. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Among the two most significant was a 2016 complaint by Pfizer alleging that claimed that Johnson & Johnson—the maker of Remicade, a best-selling medication for autoimmune disease—threatened not to pay rebates to PBMs unless they excluded from their formulary Pfizer’s biosimilar imitator to Remicade: Inflectra. [read post]